Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
26.03
-0.02 (-0.08%)
At close: Apr 15, 2025, 4:00 PM
26.19
+0.16 (0.61%)
After-hours: Apr 15, 2025, 8:00 PM EDT
Smith & Nephew Revenue
In the year 2024, Smith & Nephew had annual revenue of $5.81B with 4.70% growth. Smith & Nephew had revenue of $2.98B in the half year ending December 31, 2024, with 14.07% growth.
Revenue (ttm)
$5.81B
Revenue Growth
+4.70%
P/S Ratio
1.98
Revenue / Employee
$321,705
Employees
18,060
Market Cap
11.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
| Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
| Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
| Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
| Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| McKesson | 344.58B |
| HCA Healthcare | 70.60B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Sanofi | 45.85B |
| Thermo Fisher Scientific | 42.88B |
| GSK plc | 39.28B |
| Medtronic | 33.20B |
SNN News
- 12 days ago - Trump tariffs: these two European healthcare stocks face the highest US revenue exposure - Invezz
- 5 weeks ago - Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025 - GlobeNewsWire
- 5 weeks ago - Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025 - GlobeNewsWire
- 5 weeks ago - New report confirms Smith+Nephew's OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty - GlobeNewsWire
- 6 weeks ago - Wound Care Market Size is Expected to Reach USD 32.75 Billion by 2033, Growing at a CAGR of 3.94%: Straits Research - GlobeNewsWire
- 7 weeks ago - Smith & Nephew plc (SNN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - UK's Smith+Nephew beats annual profit expectations - Reuters
- 2 months ago - Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand - GlobeNewsWire